Mannkind earnings were $5.9M for the trailing 12 months ending Dec 31, 2025, with -80% growth year over year. The latest MNKD earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$15.9M, down 299.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MNKD reported annual earnings of $5.9M, with -78.7% growth.
MNKD past earnings growth
How has MNKD's earnings growth performed historically?
On MNKD's earnings call on Invalid Date, Mannkind (NASDAQ: MNKD) reported Q4 2025 earnings per share (EPS) of -$0.05, up 266.67% year over year. Total MNKD earnings for the quarter were -$15.95 million. In the same quarter last year, Mannkind's earnings per share (EPS) was $0.03.
As of the last Mannkind earnings report, Mannkind is currently profitable. Mannkind's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $5.86 million, a 78.75% decrease year over year.
What was MNKD's earnings growth in the past year?
As of Mannkind's earnings date in Invalid Date, Mannkind's earnings has grown -80% year over year. This is 161.14 percentage points lower than the US Biotechnology industry earnings growth rate of 81.14%. MNKD earnings in the past year totalled $5.86 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.